Status:
COMPLETED
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This trial is conducted in Africa, Asia, Europe, Oceania, and South America. The aim of this research study is to compare the efficacy (reduction in HbA1c and in blood glucose levels) of insulin detem...
Eligibility Criteria
Inclusion
- Type 1 diabetes
- Currently on basal-bolus regimen
- BMI = 35.0 kg/m2
- HbA1c =11.0%
Exclusion
- Proliferative retinopathy or maculopathy
- Recurrent major hypoglycaemia
- Cardial problems
- Uncontrolled hypertension
- Impaired hepatic or renal function
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT00184665
Start Date
June 1 2004
End Date
September 1 2006
Last Update
January 27 2017
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Buenos Aires, Argentina
2
Novo Nordisk Investigational Site
Ciudad Autonoma de Bs As, Argentina, C1405CWB
3
Novo Nordisk Investigational Site
Ciudad Autónoma de BsAs, Argentina, C1406FWY
4
Novo Nordisk Investigational Site
Mar del Plata, Argentina, B7602CBM